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Objective: To investigate the association between optimism/pessimism and concentrations of seven inflammation and hemostasis
markers. Optimism and pessimism are associated with cardiovascular disease mortality and progression; however, the biological
mechanism remains unclear. Methods: This cross-sectional study used data from the Multi-Ethnic Study of Atherosclerosis
(MESA), a study of 6814 persons aged 45 to 84 years with no history of clinical cardiovascular disease. The Life-Orientation
Test-Revised (LOT-R) was used to measure dispositional optimism and pessimism. Regression analyses were used to estimate
associations of optimism and pessimism with interleukin (IL)-6, C-reactive protein (CRP), fibrinogen, homocysteine, Factor VIII,
D-dimer, and plasmin-antiplasmin, before and after adjustment for sociodemographics, depression, cynicism, health behaviors,
body mass index (BMI), hypertension, and diabetes. Results: Higher scores on the LOT-R (positive disposition) were related to
lower concentrations of IL-6 (p  .001), fibrinogen (p  .001), and homocysteine (p  .031). Associations were stronger for the
pessimism subscale. After adjustment for demographics, the percentage differences in inflammatory markers corresponding to a
2-standard deviation increase in pessimism were 6.01% (p  .001) for IL-6, 10.31% (p  .001) for CRP, 2.47% (p  .0001) for
fibrinogen, and 1.36% (p  .07) for homocysteine. Associations were attenuated but significant after adjustment for sociodemo-
graphics, depression, cynical distrust, and behaviors. Further adjustment for hypertension, BMI, and diabetes reduced associations
for CRP and IL-6. Pessimism remained associated with a 1.36% (p  .02) increase in fibrinogen in the fully adjusted model. Factor
VIII, D-dimer, and plasmin-antiplasmin were not associated with the LOT-R or subscales. Conclusions: Pessimism is related to
higher levels of inflammation. Health behaviors, BMI, hypertension, and diabetes seem to play a mediating role. Key words:
psychosocial factors, inflammation, coagulation, epidemiology, risk factors.
CVD  cardiovascular disease; CHD  coronary heart disease;
MESA  Multi-Ethnic Study of Atherosclerosis; HTN  hypertension;
BMI  body mass index; DM  diabetes mellitus; LOT-R  Life-
Orientation Test-Revised; IL-6  interleukin-6; CRP  C-reactive
protein; CES-D  Center for Epidemiologic Studies Depression scale;
HPA  hypothalamic-pituitary-adrenal; MI  myocardial infarction;
SD  standard deviation.
INTRODUCTION
Several studies have linked life orientation, as reflected bylevels of optimism and pessimism, to cardiovascular dis-
ease (CVD) risk (1–8). Optimism is generally defined as the
tendency to believe that future expectations and goals will be
met, and is different from the absence of depression. Although
prior studies have conceptualized optimism and pessimism as
opposing poles of a continuum, recent studies showed that
they may be better characterized as distinct, negatively related
factors (9–12). Optimism has been linked to lower CVD and
coronary heart disease (CHD) mortality (5), lower rates of
nonfatal myocardial infarction (MI), slower progression of
carotid atherosclerosis (4,7,8), better outcomes after coronary
artery bypass graft procedures, and fewer restenoses after
percutaneous transluminal coronary angioplasty (13). The re-
lated construct of pessimism, defined as the general tendency
to expect negative outcomes, has been shown to be associated
with increased adverse cardiac events, including MI and death
from CHD (6), and interacts with socioeconomic status in
increasing rates of hypertension (HTN) (14).
There are several mechanisms through which optimism and
pessimism may affect CVD and its progression, but these
mechanisms have not been well established in empirical stud-
ies. Elucidating these mechanisms is important for strength-
ening causal inferences regarding the health consequences of
life orientation and will also enhance our understanding of the
etiology of CVD generally. One possible mechanistic pathway
involves health behaviors. Life orientation may affect the
adoption and maintenance of behaviors, such as diet and
physical activity, which are known risk factors for cardiovas-
cular disease. Dispositional optimism has been reported to be
associated with nonsmoking, increased physical activity, mod-
erate alcohol consumption, and more fruits, vegetables, and
whole grains in the diet (15–17). This finding may result from
optimistic persons being more likely to anticipate benefits of
behavioral change and, hence, may be more likely to adopt
and maintain these changes over time.
It is also plausible that optimism and pessimism affect health
through biological mechanisms independent of health behaviors
that have been linked to chronic inflammation and CVD. For
example, dispositional optimism may down-regulate the auto-
nomic nervous system and hypothalamic-pituitary-adrenal
(HPA) axis (18–20). In contrast, a pessimistic disposition may
stimulate chronically increased sympathetic tone and stimulation
of the HPA axis (20,21), which in turn may induce chronic
inflammation and hemostasis. Constructs related to optimism and
pessimism, such as positive affect and cynical distrust, have been
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shown to be associated with interleukin (IL)-6 and C-reactive
protein (CRP) (22,23). However, to our knowledge, the relation-
ships between optimism and pessimism and markers of inflam-
mation and hemostasis have not yet been investigated.
In this study, we explore the relationship between life-
orientation and seven circulating inflammation and hemostasis
markers that have been previously associated with increased
CVD risk: IL-6, CRP, homocysteine, fibrinogen, D-dimer,
Factor VIII, and plasmin antiplasmin (24). We use data from
the Multi-Ethnic Study of Atherosclerosis (MESA), a large
and diverse cohort of individuals ranging in age between 45
and 84 years. We hypothesized that increased optimism and
decreased pessimism would be inversely related to levels of
inflammation and hemostatic markers, and these associations
would be attenuated but remain significant after adjustment
for traditional CVD risk factors, behaviors, depression, and
cynical distrust. We investigated life orientation as a single
bipolar scale, as well as differentiated life orientation into two
distinct but negatively related constructs (optimism and pes-
simism). We hypothesized that stronger associations would be
observed with the two-factor approach.
METHODS
MESA is a longitudinal study, supported by the National Heart, Lung, and
Blood Institute, with the goal of identifying risk factors for subclinical
atherosclerosis and its progression. The study cohort consists of 6814 men and
women between the ages of 45 to 84 years, free of clinical CVD at the
baseline examination. Individuals were recruited from six field centers around
the United States, using a variety of population-based approaches, including
lists of area residents, Health Care Financing Administration lists of area
residents (for participants 65 years of age), area residents enrolled in a union
health plan, and random digit dialing. Only persons free of clinical CVD at
baseline were eligible. Among those screened and deemed eligible, the
participation rate was 59.8%. The cohort was 38% white, 28% black, 22%
Hispanic, and 12% Chinese at baseline. Repeat examinations have occurred
every 1.5 years to 2 years, with a total of four examinations to date. Details
of the study design have been published elsewhere (25). The baseline visit
took place between July 2000 and August 2002. The first follow-up visit
(during which optimism and pessimism were assessed) occurred between
September 2002 and February 2004.
Dispositional optimism, defined as the tendency to expect good outcomes
in the future, was measured, using the Life Orientation Test-Revised (LOT-R)
at the first follow-up visit. This scale is a six-item revision of the original LOT
(9,26). The LOT-R has been shown to have adequate internal consistency
(Cronbach’s   0.76), as well as 4-week (0.79) and 13-week (0.79) test-
retest reliability (26,27). It includes three positively worded and three nega-
tively worded items. The items were assessed on a 4-point Likert scale, and
negatively worded items are reverse-coded and added to the positively
worded items, creating a bipolar scale, with higher scores indicating an
optimistic disposition. Factor analysis has shown that positively and nega-
tively worded items may be summed separately, and loaded onto two separate
subscales, rather than opposing poles (9–12). We investigated both ap-
proaches to make appropriate comparisons to prior studies and fully explore
the effects of optimism and pessimism on hemostatic and inflammatory
factors. We created three partly overlapping measures: six-item full-scale
LOT-R, three positively worded items (optimism subscale), and three nega-
tively worded items (pessimism subscale). Higher values on the LOT-R and
optimism subscale measures correspond to a more positive orientation,
whereas higher levels on the pessimism subscale indicate a negative orienta-
tion. Each measure was categorized into quartiles for descriptive analyses,
with higher quartiles corresponding to higher scores within the designated
scale or subscale.
Inflammatory markers examined include IL-6, CRP, fibrinogen, and ho-
mocysteine. Hemostatic markers investigated include Factor VIIIc, D-dimer,
and plasmin-antiplasmin. These markers were selected because they are
commonly used inflammatory and hemostatis markers that have been previ-
ously linked to the occurrence of CVD events or to the development of
atherosclerosis (28–35). The inflammatory markers, IL-6, CRP, and fibrino-
gen, have been reported to be independent risk factors for CVD mortality by
contributing to endothelial dysfunction and plaque formation (28,29,31).
Homocysteine is thought to induce oxidative stress and inflammation, pro-
moting the formation of foam cells and atherosclerotic plaques, and is there-
fore considered a marker or precursor for inflammation in this study (36).
Markers of hemostasis chosen for this study, D-dimer, Factor VIII, and
plasmin-antiplasmin, are part of the coagulation cascade and fibrin cross-
linking system (31–35). Up-regulation of the coagulation pathway and dys-
function of the fibrinolytic system are hypothesized to contribute to the
prevalence of cerebrovascular accidents and myocardial infarction by increasing
susceptibility for ischemic episodes (37). Psychosocial factors like optimism
and pessimism may affect components of the inflammation or hemostasis
pathway, thereby affecting risk for incident CVD events.
Blood samples were drawn from all participants in the fasting state (or
after a noncaffeine, nonfat snack) at the baseline examination, and standard-
ized methods were used for processing and shipping to a central laboratory
(Laboratory for Clinical Biochemistry Research, University of Vermont,
Burlington, Vermont). IL-6 was measured by an ultrasensitive enzyme-linked
immunosorbent assay from R&D systems (Minneapolis, Minnesota), and the
laboratory analytical CV for this assay was 6.3%. High-sensitivity CRP and
fibrinogen were measured by nephelometry using the BNII nephelometer (N
High Sensitivity to CRP and N antiserum to human fibrinogen, Dade Behring
Inc., Deerfield, Illinois). The intra-assay and interassay analytical CVs for
CRP ranged from 2.3% to 4.4% and from 2.1% to 5.7%, respectively.
Corresponding CVs for fibrinogen were 2.7% and 2.6%, respectively. Plasma
homocysteine was measured by fluorescence polarization immunoassay with
an IMx analyzer (IMx Homocysteine Assay, Axis Biochemicals ASA, Oslo,
Norway). The laboratory analytical CV range was 3.8% to 5.1%. Factor VIII
coagulant activity was measured, using the Sta-R analyzer (STA-Deficient
VIII, Diagnostica Stago, Parsippany, New Jersey) with an analytical CV of
10%, D-dimer by immunoturbidometric methods on the Sta-R analyzer (Li-
atest D-DI, Liatest VWF, Diagnostica Stago, Parsippany, New Jersey) with an
analytical CV of 8%, and plasmin-antiplasmin by a two-site enzyme-linked
immunosorbent assay that utilizes two monoclonal antibodies, with an ana-
lytical CV of 1.7%.
Sociodemographic information, medical history, health behavior, and
cardiovascular risk factor characteristics were obtained by questionnaires
during the baseline examination. Education was classified into three groups:
less than high school; complete high school or equivalent; and complete
college or higher education. Household income over the last 12 months was
divided into five categories: $12,000; $12,000 to $25,000; $25,000 to
$40,000; $40,000 to $75,000; and $75,000. Race and ethnicity were re-
ported based on the participants’ responses to questions modeled after the
2000 U.S. Census measure.
Behavioral risk factors included smoking, diet, and physical activity.
Cigarette smoking was quantified by pack-years of use. Physical activity was
assessed, using a questionnaire adapted from the Cross-Cultural Activity
Participation (38), and a composite measure of activity time and level of
intensity were used to calculate total intentional exercise activity in metabolic
equivalent-minutes/week. Dietary patterns were gauged, using a 120-item,
modified-Block style, food frequency questionnaire, and were summarized
using four factors derived using factor analysis: “fats and processed meats”
(Western); “vegetables and fish” (Chinese); “beans, tomatoes, and refined
grains” (Hispanic); and “whole grains and fruits” (prudent) (39).
Other covariates included diabetes, HTN, body mass index (BMI), recent
infection, current use of medications known to alter inflammatory response,
fasting state, cynical distrust, and depression. Diabetes was defined by the
2003 American Diabetes Association’s criteria of fasting plasma glucose
126 mg/dL (40), or use of insulin or other diabetes medications. Hyperten-
sion was classified by the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure IV 1997 criteria, of
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diastolic blood pressure 90 mm Hg or systolic blood pressure 140 mm Hg
or self-reported history of HTN or current use of any hypertensive medica-
tions. BMI was calculated as weight over height (in meters) squared. Partic-
ipants were categorized as having a recent infection if they reported having a
cold/flu, sinus, urinary or tooth infection, bronchitis, or pneumonia in the last
2 weeks. Medication use was a binary variable created for individuals who
were currently using lipid-lowering medications, nonsteroidal anti-inflammatory
drugs, or aspirin. Participants were considered to be fasting if the last thing the
person ate or drank was 8 hours before the blood sample was obtained.
Depression was measured using the 20-item Center for Epidemiologic Studies-
Depression questionnaire (CES-D) (41). Cynical distrust was measured by an
eight-item subset of the Cook-Medley hostility scale, which has previously
been shown to relate to CVD (42–44).
Biomarkers of inflammation and hemostasis were log-transformed for
analyses, and back-transformed to the original metric as geometric means for
presentation. In descriptive analyses, we examined gradients of inflammatory
and hemostatic markers as well as key covariates across quartiles of optimism,
after adjusting for age, sex, and race/ethnicity using 2 tests. Linear regression
was used to estimate the association of each log-transformed inflammatory
and hemostatic marker with the optimism measures after adjustment for
potential confounders or mediators. Given that no clear threshold effects were
observed in descriptive analyses, optimism and pessimism were investigated
as continuous predictors. To facilitate interpretation, exponentiated regression
coefficients from regression models with logged continuous outcomes are
reported as percent differences in the circulating level of the biomarkers
associated with a difference in the optimism or pessimism levels equivalent to
2 standard deviation (SD) in the sample.
The associations of optimism/pessimism with inflammation and hemosta-
sis markers were initially investigated in a base model (model 1), which was
adjusted for demographic characteristics (age and sex), fasting state, recent
infections, and medication use. In models for subscales, we also adjusted for
the opposing LOT-R subscale (i.e., if optimism was the predictor, then the
analysis was adjusted for pessimism). Next, the confounding effect of socio-
economic position and negative psychosocial factors was assessed in model 2
by adding measures of race/ethnicity, household income and education,
depression and cynical distrust to the base model. Model 3 additionally
adjusted model 2 for health behaviors, including pack-years of cigarette use,
diet, and physical activity. Model 4 further adjusted model 3 for biomedical
risk factors, including HTN, BMI, and diabetes mellitus (DM). Heterogeneity
in associations of optimism with the outcomes by race/ethnicity, sex, and
depression were examined by including appropriate interaction terms in
model 1. Of 63 tests, only six tests were statistically significant. Inspection of
statistically significant interactions using plots revealed no consistent or
substantial effect modification so analyses were subsequently adjusted for
these factors.
All reported probability values correspond to two-tailed tests, which were
considered significant at the .05 level. The study was approved by Institu-
tional Review Boards at all participating institutions. All subjects gave their
written informed consent.
RESULTS
Means for selected characteristics of the full sample
(6195), and for those in each quartile of the LOT-R and its
subscales are shown in Table 1. The mean age was 62.1 years;
the sample was 52% female and 38.5% self-identified as
white, 11.8% as Chinese, 27.8% as African American, and
22.0% as Hispanic. The geometric means (SD) of the
biomarkers for the full sample were 1.24 pg/mL (1.22
pg/mL) for IL-6, 1.92 mg/dL (3.2 mg/dL) for CRP, 339.31
mg/dL (73.9 mg/dL) for fibrinogen, 8.87 mol/L (3.75) for
homocysteine, 0.22 mol/L (0.87 mol/L) for D-dimer,
150.83% (67.0%) for Factor VIII, and 4.43 nM (2.19 nM)
for plasmin-antiplasmin.
TABLE 1. Demographic, Behavioral, and Biological Characteristics of Study Population by Categories of Optimism Measures, Adjusted for Age,










































62.2 53 38 48851 13.04 1553 13 2.03 28.34 13 45 22 53
LOT-R 19.9
Quartile 1 15.7 62 53 40 44842 12.7 1515 15 1.93 28.44 14 45 22 52
Quartile 2 20.1 61.5 51 41 50900 13.42 1609 13 2.01 28.32 12 42 23 53
Quartile 3 22.5 61.9 53 44 55785 13.84 1600 11 2.13 28.37 10 45 22 55
Quartile 4 24 62.7 53 31 50811 12.99 1573 10 2.15 27.85 10 44 24 53




Quartile 1 6.8 61.8 54 48 47161 12.94 1400 15 1.95 28.37 13 43 22 53
Quartile 2 9.5 61.5 51 46 53895 13.66 1635 13 2.07 28.24 11 42 23 55
Quartile 3 11 61.7 53 38 53013 13.54 1648 12 2.03 28.61 13 45 22 54
Quartile 4 12 62.7 51 29 46618 12.78 1590 11 2.06 28.11 11 46 23 52




Quartile 1 3 62.6 54 42 55365 13.49 1619 11 2.14 27.99 10 42 23 55
Quartile 2 4 61.2 52 43 54227 13.91 1540 11 2.1 28.49 10 45 23 56
Quartile 3 5.5 61.7 51 40 46701 12.97 1613 14 1.98 28.34 13 44 22 52
Quartile 4 8.3 61.9 53 34 42901 12.56 1478 15 1.89 28.54 15 47 23 51
p for trend .022 .35 .001 .002 .002 .26 .001 .002 .008 .002 .01 .882 .012
MESA  Multi-Ethnic Study of Atherosclerosis; MET  metabolic equivalent; BMI  body mass index; DM  diabetes mellitus; HTN  hypertension;
LOT-R  Life-Orientation Test-Revised.
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Of the 6195 participants at the first MESA follow-up
examination on whom optimism was measured, 5220 to 5358
participants (depending on the outcome measure) had com-
plete information on all relevant covariates and were included
in subsequent analyses. The internal consistency of the LOT-R
was 0.73, and was fairly similar (0.66–0.78) across both sexes
and all four race/ethnic groups. Factor analysis of the six-item
LOT-R confirmed loading of items onto two separate factors,
termed “optimism subscale” and “pessimism subscale.” Sim-
ilar reliabilities were observed for the optimism and pessi-
mism subscales (Cronbach’s   0.72 and 0.71, respectively).
The correlation between the optimism and pessimism sub-
scales was 0.33 (p  .0001). The correlations between the
LOT-R and the CES-D and the pessimism subscale and
CES-D were 0.35 and 0.30, respectively. The correlations
between the LOT-R and cynical distrust and between pessi-
mism and cynical distrust were 0.19 and 0.27, respectively.
Generally, older individuals tended to have higher levels of
optimism and lower levels of pessimism although differences
in age across quartiles were not graded (Table 1). There was
no association between optimism or pessimism and gender.
The percent of minority participants increased with increasing
levels of both the optimism and the pessimism subscales. The
most consistent associations between life orientation measures
and socioeconomic indicators were observed for the pessi-
mism subscale: higher pessimism levels were associated with
lower income and education in a graded fashion. In general,
higher levels of optimism and lower levels of pessimism were
also associated with greater physical activity (statistically sig-
nificant for optimism subscale only), nonsmoking, diets richer
in whole grains and vegetables, lower BMI, and less DM. In
all cases, associations were most consistent for the pessimism
subscale.
In bivariate analyses (Table 2), higher scores on the LOT-R
were generally associated with lower levels of IL-6, CRP,
fibrinogen, and homocysteine (although associations with
CRP were not statistically significant). No clear patterns were
observed for D-dimer, Factor VIII, and plasmin-antiplasmin.
In general, the association between the full scale LOT-R and
IL-6, CRP, fibrinogen, and homocysteine were driven by the
pessimism factor: All four markers were positively associated
with higher scores on the pessimism subscale but were not
consistently associated with the optimism subscale. D-dimer,
Factor VIII, and plasmin-antiplasmin were not consistently
associated with the optimism or pessimism subscales and,
therefore, are not reported in subsequent analyses.
Table 3 shows the multivariate adjusted percent differences in
inflammatory factors associated with a subscale difference equiv-
alent to 2 SD in the optimism and pessimism subscales. These
were estimated, using a model with optimism and pessimism
subscales entered as continuous variables. After adjustment for
age, sex, current infection, current medication use, fasting state,
and opposing subscale, a 2-SD increase in the optimism subscale
was associated with a 7.67% increase in CRP (p  .02). The
optimism subscale was not significantly associated with IL-6,
fibrinogen or homocysteine in any of the four models. Further
adjusting for race/ethnicity, income, education, depression, and
cynical distrust (model 2) resulted in attenuation of the associa-
tion with CRP (4.93% increase, p  .12). In the final model, after
accounting for effects of health behaviors, HTN, DM, and BMI,
a 2-SD increase in the optimism subscale was associated with a
TABLE 2. Geometric Means for Markers of Chronic Inflammation and Hemostatis by Categories of Optimism Measures, Adjusted for Age,
Race, Sex, MESA 2000 to 2002
Optimism Measure
IL-6 CRP Fibrinogen Homocysteine D-dimer Factor VIII PAP
(pg/mL) (mg/dL) (mg/dL) (mol/L) (g/mL) (%) (nM)
Full sample (n  6195) 1.24 1.92 339.31 8.87 0.22 150.83 4.43
LOT-R
Quartile 1 1.21 1.75 342.1 8.91 0.21 149.75 4.36
Quartile 2 1.22 1.77 336.57 8.83 0.21 150.14 4.29
Quartile 3 1.14 1.67 334.22 8.71 0.21 148.34 4.28
Quartile 4 1.13 1.68 333.45 8.67 0.21 148.56 4.26
p value for trend .001 .39 .001 .03 .89 .81 .32
Optimism subscale
Quartile 1 1.19 1.68 339.61 8.94 0.21 148.03 4.32
Quartile 2 1.2 1.74 337.48 8.77 0.21 150.07 4.35
Quartile 3 1.17 1.76 336.6 8.71 0.22 149.46 4.23
Quartile 4 1.16 1.74 336 8.79 0.21 149.49 4.29
p value for trend .36 .72 .5 .09 .86 .83 .26
Pessimism subscale
Quartile 1 1.13 1.64 332.99 8.7 0.21 148.59 4.27
Quartile 2 1.19 1.73 336.8 8.68 0.2 150.88 4.33
Quartile 3 1.2 1.75 338.05 8.94 0.22 149.26 4.3
Quartile 4 1.22 1.81 342.41 8.87 0.21 149.86 4.33
p value for trend .004 .05 .001 .005 .09 .79 .64
MESA  Multi-Ethnic Study of Atherosclerosis; IL  interleukin; CRP  C-reactive protein; PAP  plasmin-antiplasmin; LOT-R  Life-Orientation
Test-Revised.
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5.47% increase in CRP, but this difference was not quite statis-
tically significant (p  .09).
Associations of inflammatory markers with the pessimism
subscale were stronger and more consistent than those observed
for the optimism subscale. In the base model, a 2-SD increase in
the pessimism subscale was significantly related to a 6.01%
increase in IL-6 (p  .001), 10.31% increase in CRP (p  .001),
and a 2.47% increase in fibrinogen (p  .0001). The 1.36%
increase associated with homocysteine was not quite statistically
significant (p  .07). After sociodemographic and other psycho-
social factors were added into the model (model 2), a 2-SD
increase in pessimism was still associated with a 3.29% increase
in IL-6 (p  .08), an 8.16% increase in CRP (p  .01) and a
1.77% increase in fibrinogen (p  .002). Further adjustment for
health behaviors in model 3 did not have much additional effect.
A 2-SD increase in pessimism remained associated with higher
levels of inflammatory markers: 3.71% for IL-6 (p  .06), 8.25%
for CRP (p  .02), and 1.86% for fibrinogen (p  .002).
Adjustment for HTN, BMI, and diabetes in model 4 diminished
associations with IL-6 and CRP to 1.26% (p  .5) and 4.26%
(p  .19), respectively. Associations of pessimism with fibrino-
gen remained statistically significant in the fully adjusted model
(a 2-SD increase in pessimism was associated with a 1.36%
increase in fibrinogen, p  .02).
DISCUSSION
Overall, this study showed that higher scores on the LOT-R
scale (indicative of higher levels of optimism generally) were
associated with lower levels of IL-6, CRP, fibrinogen, and
homocysteine, but not D-dimer, Factor VIII, or plasmin-anti-
plasmin. When the LOT-R was divided into optimism and
pessimism subscales, the pessimism subscale was more
strongly associated with inflammatory markers than the opti-
mism subscale, with higher levels of pessimism being associ-
ated with higher levels of IL-6, CRP, and fibrinogen in a
dose-response fashion. The relationship held after the effects
of sociodemographics, negative psychosocial factors, and
health behaviors were accounted for. Results are compatible
with a mediating role of BMI, HTN, and DM, as adjustment
for these factors greatly diminished the association between
pessimism and IL-6, CRP, and fibrinogen. Only fibrinogen
remained associated with pessimism after full adjustment,
which suggests that other unstudied mechanisms may also be
involved. In our model, the strength of the associations of
pessimism with inflammatory markers are similar to those
observed for increase of 10 years of age, but smaller than
those observed for diabetes. The magnitudes of the effect sizes
are also similar to those reported for cynical distrust in the
same sample (22).
Our results add to the growing body of literature on the
effect psychosocial factors on CVD development and progres-
sion. This study is the first to investigate the associations of
optimism and pessimism with inflammation and coagulation.
We found that the pessimism subscale had a stronger associ-
ation with the outcome variables than the full LOT-R or the
optimism subscale, and the associations were independent of
the effects of depression and cynical distrust. Other studies
that have analyzed optimism and pessimism factors separately
have found similar results. Räikkönen and Matthews reported
that the pessimism subscale had a stronger association with
ambulatory blood pressure than either the full-scale LOT-R or
the optimism subscale (12). Shen et al. also found that pessi-
mism was a stronger predictor than optimism of worse phys-
ical functioning after 6 weeks of cardiac rehabilitation (45).
Taken together, these results suggest that pessimism has more
pronounced physiologic effects than optimism. However, it is
also plausible that the so-called pessimism items (i.e., nega-
tively worded items) are simply better measures of disposi-
tional optimism than the positively worded items, and that
dispositional is the relevant psychosocial construct.
In a model adjusted for demographics and pessimism, opti-
mism was associated with higher rather than lower CRP. How-
TABLE 3. Percent Differences (% diff) in Inflammatory Biomarkers Associated With a 2-Standard Deviation Increase in Optimism and
Pessimism Subscales of the LOT-R in MESA 2001 to 2002
LOT-R
Subscale
IL-6 CRP Fibrinogen Homocysteine
% diff 95% CI p % diff 95% CI p % diff 95% CI p % diff 95% CI p
Optimism
Model 1 1.95 (1.52, 5.54) .27 7.67 (1.43, 14.3) .02 0.44 (0.61, 1.51) .41 0.71 (2.14, 0.74) .33
Model 2 0.66 (2.9, 4.31) .72 4.93 (1.29, 11.5) .12 0.46 (1.55, 0.64) .41 1.00 (2.5, 0.52) .20
Model 3 2.42 (1.4, 6.3) .21 7.80 (1.11, 14.9) .02 0.45 (1.6, 071) .45 1.07 (2.64, 0.51) .18
Model 4 1.23 (2.3, 4.9) .50 5.47 (0.74, 12.1) .09 0.69 (1.8, 0.44) .23 1.22 (2.78, 0.36) .13
Pessimism
Model 1 6.01 (2.4, 9.75) .001 10.31 (3.91, 17.09) .001 2.47 (1.4, 3.56) .001 1.36 (0.1, 2.85) .07
Model 2 3.29 (0.42, 7.13) .08 8.16 (1.58, 15.15) .01 1.77 (0.62, 2.92) .002 0.69 (0.88, 2.28) .39
Model 3 3.71 (0.2, 7.74) .06 8.25 (1.42, 15.53) .02 1.86 (0.66, 3.07) .002 0.89 (0.74, 2.54) .28
Model 4 1.26 (2.33, 4.98) .50 4.26 (1.99, 10.9) .19 1.36 (0.2, 2.53) .02 0.62 (1.0, 2.27) .45
LOT-R  Life-Orientation Test-Revised; MESA  Multi-Ethnic Study of Atherosclerosis; IL  interleukin; CRP  C-reactive protein; CI  confidence
interval.
Model 1: Adjusted for age, sex, current infection, current medication use, fasting state, and opposing subscale; Model 2: additionally adjusts model 1 for race,
education, income, depression, and cynical distrust; Model 3: additionally adjusts model 2 for smoking, exercise, and diet; Model 4: additionally adjusts model
3 for BMI, diabetes, and hypertension.
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ever, this finding was not consistent across models or different
inflammatory markers and may be spurious. Although optimism
specifically has not previously been linked to chronic inflamma-
tion, trait positive affect, a similar attribute, was associated with
lower IL-6 and CRP among women aged 50 to 74 years in the
Whitehall Study (23). Similarly, Ryff et al. reported an inverse
association between higher levels of “purpose in life,” a factor in
the eudaimonic well-being scale, and IL-6 in older women (ages
65 and older) (46). Our findings are congruent with Pressman’s
and Cohen’s “main effect model” which postulates that behav-
ioral and biological pathways mediate the link between psycho-
logic traits and the immune and cardiovascular systems (19). In
our study, once behavioral risk factors were controlled for in
model 3, the associations with pessimism diminished, as would
be expected for a mediating role in this model. Giltay et al. also
reported that optimism was associated with health behaviors,
such as nonsmoking, increased physical activity, and better diet,
adding further support to the model (15). This may occur because
people with higher levels of optimism believe they have the
ability to change the course of their health and, thereby, tend to
adopt better health behaviors. These individuals may also have
better self-care behaviors, obtaining more information about their
disease and adhering to treatment regimens (19).
Dispositional optimism and pessimism may also directly in-
fluence the autonomic nervous system and HPA axis (18–20).
Lower levels of blood pressure and cortisol have been reported
among those with greater optimism (12,45,47). Similarly,
Fredrickson and Levenson demonstrated faster cardiovascular
recovery from acute increases in blood pressure and heart rate in
response to negative emotional stimuli among those with higher
levels of optimism (48). In contrast, a pessimistic disposition may
provoke feelings of self-blame, fatalism, and catastrophic think-
ing, which leads to chronically increased sympathetic tone and
cortisol levels (20,21). We did not directly investigate these
mechanisms but the persistence of associations with fibrinogen in
the fully adjusted models suggests that other mechanisms, per-
haps involving physiologic stress processes, could play a role.
The effects of dispositional optimism or pessimism may
have long-term systemic effects throughout the life course.
Two prospective cohort studies reported that more optimistic
individuals have lower rates of MI and mortality from CHD
death (5,6) than pessimistic individuals over 10 years to 15
years. Matthews et al. reported that higher pessimism scores
resulted in greater increases over time in mean carotid intima-
media thickness over the course of 10.4 years (7). The present
study adds a plausible mechanism for these findings: If pes-
simistic orientation is developed in young adulthood, the
chronically increased levels of inflammatory factors may con-
tribute to the progression and clinical manifestation of CVD.
We did not find any association between the LOT-R and three
measured hemostatic markers (D-dimer, Factor VIII, and plas-
min-antiplasmin). We are not aware of other studies that have
investigated the association of life-orientation with hemostasis.
Although Factor VIII and D-dimer have been shown to increase
with acute stress and sympathetic nervous system activation
(49–53), it may be that they do not remain chronically elevated
in relationship to trait dispositional pessimism or low optimism.
This study was conducted in a large, diverse, well-charac-
terized sample free of CVD. Although excluding individuals
with clinical CVD may have resulted in underestimates of
associations, it precluded confounding by disease status. We
used the LOT-R, a widely used, validated measure of dispo-
sitional optimism, to measure optimism and pessimism
(10,11,26,54). We measured life orientation at the first fol-
low-up visit, which was 2 years after the initial visit, when
inflammatory markers were measured. However, life orienta-
tion is considered a stable trait, and remains relatively
unchanged over the course of an individual’s lifetime (5).
Therefore, it is unlikely that individual scores on the LOT-R
changed significantly over the course of the 2 years between
visits. Analyses were cross-sectional, limiting causal infer-
ences. However, given that dispositional optimism is a stable
trait, usually developed in young adulthood (21,55), it is likely
an antecedent factor to mediating health behaviors and bio-
logic pathways that affect CVD progression and outcomes.
In summary, we found that pessimism was associated with
higher levels of markers for systemic inflammation in a large,
healthy, diverse population. These associations were independent
of depression and cynical distrust. Our results are consistent with
a mediating role of health behaviors, BMI, HTN, and DM. This
may have implications for programs aimed toward primary or
secondary prevention of CVD, as the cultivation of optimism
may be an important feature of program design.
We thank the other investigators, the staff, and the participants of the
MESA study for their valuable contributions. A full list of participating
MESA investigators and institutions can be found at www.mesa-nhlbi.org.
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